A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier

Neuro-degenerative Diseases
Corbin BachmeierFiona Crawford

Abstract

While apolipoprotein E4 (apoE4) is highly correlated with the development of Alzheimer's disease (AD), its role in AD pathology and, in particular, beta-amyloid (Aβ) removal from the brain, is not clearly defined. To elucidate the influence of apoE on the clearance of Aβ across the blood-brain barrier (BBB). Aβ(1-42) was intracerebrally administered to transgenic mice expressing human apoE isoforms and examined in the periphery. apoE3 and apoE4 mice had 5 times and 2 times, respectively, more Aβ(1-42) appearing in the plasma than wild-type or apoE knockout mice, indicating an enhanced clearance of Aβ from the brain to the periphery. In vitro, unbound basolateral apoE3 (i.e., not bound to Aβ), and to a lesser extent unbound apoE4, at concentrations ≤10 nM facilitated basolateral-to-apical fluorescein-Aβ(1-42) transcytosis across a BBB model, while apoE isoforms bound to Aβ significantly disrupted Aβ transcytosis. Additionally, following apical exposure to the BBB model, we found that apoE4 bound to Aβ is able to penetrate the BBB more readily than apoE3 bound to Aβ and does so via the RAGE (receptor for advanced glycation end products) transporter. These studies indicate a multifaceted, isoform-dependent role for apoE in the exc...Continue Reading

References

Dec 1, 1980·The Journal of Clinical Investigation·C B BlumR Sciacca
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Mar 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M HoltzmanS M Paul
Aug 15, 2000·The Journal of Biological Chemistry·M J LaDuL J van Eldik
Jun 8, 2004·Journal of Molecular Neuroscience : MN·Ling GuoLinda J Van Eldik
Aug 24, 2004·Nature Reviews. Neuroscience·Martin Citron
May 17, 2005·Brain Research. Molecular Brain Research·Daniel ParisMike Mullan
Nov 2, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Robert D BellBerislav V Zlokovic
Jun 7, 2007·Nature Reviews. Neuroscience·Frank M LaFerlaSalvatore Oddo
Aug 19, 2007·Nature Medicine·Abhay SagareBerislav V Zlokovic
Apr 2, 2008·Journal of Neuropathology and Experimental Neurology·John E Donahue, Conrad E Johanson
May 13, 2008·Neuropsychologia·Agneta Nordberg
Nov 7, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David R RiddellPeter H Reinhart
Nov 26, 2008·The British Journal of Nutrition·Juan Antonio MorenoJosé López-Miranda
Nov 27, 2008·The Journal of Clinical Investigation·Rashid DeaneBerislav V Zlokovic
May 29, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kelly R BalesSteven M Paul
Aug 15, 2009·Neuron·Jungsu KimDavid M Holtzman
May 1, 2010·Nature Reviews. Drug Discovery·Martin Citron
Dec 15, 2010·Science·Kwasi G MawuenyegaRandall J Bateman
Mar 23, 2011·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Corbin J BachmeierDaniel Paris

❮ Previous
Next ❯

Citations

Aug 15, 2012·Journal of Molecular Neuroscience : MN·Corbin BachmeierDaniel Paris
May 14, 2014·Annual Review of Neuroscience·Jin-Tai YuJohn Hardy
Jul 13, 2014·Neuromolecular Medicine·Corbin BachmeierFiona Crawford
Feb 18, 2016·Acta Neuropathologica·Leon M TaiGuojun Bu
Apr 2, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Shanker SwaminathanUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 9, 2013·Molecular and Cellular Neurosciences·Corbin BachmeierDaniel Paris
Aug 10, 2016·Fluids and Barriers of the CNS·B ShackletonC Bachmeier
Sep 21, 2016·Journal of Molecular Neuroscience : MN·Laura Mahoney-SanchezScott Ayton
Aug 8, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Michelle A Erickson, William A Banks
Jun 19, 2019·Molecular Neurobiology·Ben ShackletonCorbin Bachmeier
Apr 12, 2013·Expert Opinion on Therapeutic Targets·Henna MartiskainenMikko Hiltunen
Oct 8, 2015·Journal of Alzheimer's Disease : JAD·Hyeong Jun KimSun Ah Park
May 4, 2017·The AAPS Journal·Mitchell P McInerneyJoseph A Nicolazzo
Mar 12, 2019·Scientific Reports·Benjamin GoudeyUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Nov 6, 2018·Neurochemical Research·Helen A RowlandKatherine A B Kellett
May 28, 2016·Journal of Alzheimer's Disease : JAD·Cristina Merino-ZamoranoMar Hernández-Guillamon
Apr 15, 2021·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Hao WangShu-Cun Qin
May 1, 2021·International Journal of Molecular Sciences·Tânia Soares MartinsAna Gabriela Henriques

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.